Coloplast A/S Stock

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen 10:59:50 2024-04-17 am EDT 5-day change 1st Jan Change
900.4 DKK -1.62% Intraday chart for Coloplast A/S -2.66% +16.63%
Sales 2024 * 27.21B 3.89B Sales 2025 * 29.58B 4.23B Capitalization 202B 28.95B
Net income 2024 * 5.34B 763M Net income 2025 * 6.22B 889M EV / Sales 2024 * 8.14 x
Net Debt 2024 * 19.06B 2.73B Net Debt 2025 * 17.59B 2.52B EV / Sales 2025 * 7.44 x
P/E ratio 2024 *
37.7 x
P/E ratio 2025 *
32.4 x
Employees 15,751
Yield 2024 *
2.28%
Yield 2025 *
2.49%
Free-Float 58.39%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.62%
1 week-1.53%
Current month-3.43%
1 month-4.15%
3 months+14.82%
6 months+24.02%
Current year+16.63%
More quotes
1 week
899.60
Extreme 899.6
947.20
1 month
899.60
Extreme 899.6
947.20
Current year
757.80
Extreme 757.8
977.60
1 year
689.20
Extreme 689.2
993.00
3 years
689.20
Extreme 689.2
1 194.00
5 years
680.20
Extreme 680.2
1 194.00
10 years
413.10
Extreme 413.1
1 194.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 07-12-31
Director of Finance/CFO 52 05-12-31
Chairman 65 87-12-31
Members of the board TitleAgeSince
Director/Board Member 76 68-09-30
Director/Board Member 60 17-11-30
Chairman 65 87-12-31
More insiders
Date Price Change Volume
24-04-17 900.4 -1.62% 137,835
24-04-16 915.2 +0.04% 182,039
24-04-15 914.8 +0.79% 124,558
24-04-12 907.6 -2.81% 244,374
24-04-11 933.8 +0.95% 221,376

Delayed Quote Nasdaq Copenhagen, April 17, 2024 at 10:59 am EDT

More quotes
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
900.4 DKK
Average target price
917.1 DKK
Spread / Average Target
+1.85%
Consensus
  1. Stock Market
  2. Equities
  3. COLO B Stock